Generic
Eszopiclone
16 brands available in the market
At a glance
Eszopiclone is a sedative-hypnotic medication used for the treatment of insomnia. It reduces sleep onset time and frequent awakening at night.
Description
Eszopiclone is a prescription medicine used to treat insomnia. It reduces sleep onset time and frequent awakening at night. This medicine improves sleep maintenance and therefore ensures sound sleep.
Eszopiclone belongs to a group of medicines called sedative-hypnotics. It works by slowing activity of the nerve cells in the brain and helps fall asleep.
Indications
- Insomnia: Indicated for the management of insomnia, including difficulty in falling asleep, difficulty in maintaining sleep during the night, and waking up too early in the morning.
Pharmacological class
Non-benzodiazepine Hypnotic
Pharmacology
Eszopiclone (S-isomer of Zopiclone) is a sedative/hypnotic. It is a non-benzodiazepine that works via interaction with GABA-receptor complexes. It is rapidly absorbed and have elimination half-life (t 1/2) of approx. 6 hours in non-elderly adults. In the elderly, half life is approx. 9 hours.
Mechanism of action
Eszopiclone is a nonbenzodiazepine hypnotic. The exact mechanism of action is unknown, its effect is associated with the interaction with GABA-receptor complex.
Dosage
Adult Dose:
- Insomnia (18-64 years): 2 mg immediately before bedtime; may increase to 3 mg if clinically indicated.
- Elderly (>=65 years, difficulty falling asleep): 1 mg; may increase to 2 mg if needed.
- Elderly (difficulty staying asleep): 2 mg.
- Severe hepatic impairment: Max: 2 mg daily.
Child Dose: Safety and efficacy not established.
Administration
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Eszopiclone is to be taken on an empty stomach.
Missed dose
If you miss a dose of Eszopiclone, please consult your doctor.
Drug interactions
Drug Interactions:
- CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin, nefazodone, ritonavir, nelfinavir): May increase plasma concentrations; dosage reduction may be needed.
- CYP3A4 inducers (rifampicin): May reduce concentrations.
- Alcohol, anticonvulsants, antihistamines, psychotropic drugs: May enhance adverse CNS effects.
- Flumazenil: May diminish sedative effect.
Food interactions
Food Interactions: It is unsafe to consume alcohol with Eszopiclone. Alcohol may enhance sedative effects.
Contraindications
Contraindications:
- Hypersensitivity
- Depression (caution)
- Severe Chronic Obstructive Lung Disease
- Severe Liver Disease
- Weakened Patient
- Having thoughts of Suicide
Side effects
Common Side Effects:
- Sleepiness
- Dizziness
- Headache
- Taste change
- Dryness in mouth
- Rash
- Anxiety
- Hallucination
- Respiratory tract infection
- Viral infection
- Difficulty with coordination
Use in pregnancy
Use in Pregnancy: Category C. Animal studies have shown harmful effects on the developing baby. Should be used only if potential benefit justifies potential risk to the fetus.
Pregnancy Category: C — always consult a doctor before taking during pregnancy.
Use in lactation
Use in Lactation: Eszopiclone is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Monitor baby for excessive sleepiness.
Precautions & warnings
Precautions:
- Eszopiclone may impair alertness and motor coordination; risk of morning impairment increases with dose.
- Take on an empty stomach (high-fat meal reduces absorption and effect).
- Take 30-45 minutes before bedtime and only when you have time to sleep for at least 7 hours.
- It makes you feel dizzy next morning; don't drive or do anything requiring concentration.
- Inform your doctor if sleep doesn't improve after 7-10 days.
- Stop taking and inform doctor if sleep driving or memory loss occurs.
- Inform doctor if behavioral changes, new or worsening depression or suicidal thoughts occur.
- Do not stop taking suddenly (may lead to anxiety, mood changes, restlessness).
Pediatric use
Pediatric Use: Pediatric dosing is not available.
Geriatric use
Geriatric Use: Elderly dose: difficulty falling asleep: 1 mg, may increase to 2 mg; difficulty staying asleep: 2 mg.
Renal / hepatic impairment
Renal Impairment: Safe to use in patients with kidney disease; no dose adjustment recommended.
Hepatic Impairment: Use with caution in severe liver disease; dose adjustment may be needed; mild-moderate liver disease: no dose adjustment recommended.
Overdose effects
Overdose: Limited pre-marketing clinical experience. One case of overdose with up to 36 mg reported where subject fully recovered.
Therapeutic class
Miscellaneous sedatives and hypnotics
Storage conditions
Storage: Keep below 30 degree C temperature, away from light and moisture. Keep out of reach of children.
Chemical structure
Eszopiclone